| Literature DB >> 32190494 |
N R Venkatesh1, Chellappa Vijayakumar1, Gopal Balasubramaniyan1, Sakthivel Chinnakkulam Kandhasamy1, Sudharsanan Sundaramurthi1, Sreenath G S1, Krishnamachari Srinivasan1.
Abstract
Background Acute pancreatitis (AP) is an inflammatory condition of the pancreas mostly due to alcohol or gallstones. Various scoring systems were involved in identifying the severity of the disease. The standard single score to identifying the severity remains uncertain. Methodology This prospective observational study was carried out for two years in a tertiary care center from South India. The diagnosis of AP was made based on Atlanta criteria, and a total of 164 patients were included. All patients were assessed by acute physiology and chronic health evaluation ll (APACHE II), bedside index for severity in AP (BISAP), modified Glasgow score (MGS), and Ranson score on admission and 48 hours after admission scores. Procalcitonin was done in all patients with AP. Contrast-enhanced computed tomography (CT) of the abdomen was done in 69 patients who had features of severe acute pancreatitis (SAP). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy were calculated for each score, and procalcitonin for CT documented severe patients and organ failure patients together. Results A total of 164 patients were included in this study. CT abdomen showed a modified CT severity index (MCSI) ≥8 in all 69 (100%) patients. APACHE II score could predict SAP based on CT findings in 44 patients (63.76%), BISAP score in 22 patients (31.88%), MGS in 55 patients (79.71%), Ranson score at admission in 31 patients (44.92%), Ranson score 48 hours after admission in 44 patients (63.76%), and procalcitonin on admission in 69 patients (100%) when cut-off used as per the literature. APACHE II score could predict SAP in cases of AP (n=164) in 52 patients (50%), BISAP score in 27 patients (26%), MGS in 79 patients (76%), Ranson score at admission in 34 patients (33%), and Ranson score 48 hours after admission in 61 (59%) patients when cut-off was used as per the literature. This study demonstrated that Ranson score on admission had a good area under the curve (AUC). AUC (0.8483), APACHE II (AUC 0.7708), and Ranson score 48 hours after admission (AUC 0.8167) had a fair accuracy. BISAP (AUC 0.6399) and MGS (AUC 0.6486) had poor accuracy for the prediction of severity in AP based on receiver operator characteristic (ROC) curves. Conclusion Among the scoring system compared, MGS had the highest sensitivity for predicting the severity of AP. However, Ranson score on admission had better diagnostic accuracy for predicting severity, organ failure, and mortality based on ROC curves. Procalcitonin had the best sensitivity, specificity, PPV, NPV, and diagnostic accuracy for association with severity in AP.Entities:
Keywords: acute pancreatitis; apache ii score; bisap score; modified glasgow score; procalcitonin; ranson score
Year: 2020 PMID: 32190494 PMCID: PMC7067369 DOI: 10.7759/cureus.6943
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Etiology of pancreatitis in study patients
| Etiology | No of patients (n=164) |
| Alcohol | 115 (70.1%) |
| Gallstone disease | 33 (20.12%) |
| Idiopathic | 15 (9.1%) |
| Hypertriglyceridemia and gallstone disease | 20 (12.2%) |
| Trauma | 1 (0.06%) |
Complications diagnosed with gold standard CT abdomen in study patients
MCSI: modified CT severity index
| Complications | No of patients (n=69) |
| Acute fluid collection | 56 (81.15%) |
| Necrotizing pancreatitis | 49 (71.01%) |
| Splenic vein thrombosis | 12 (17.39%) |
| Pleural effusion/ascites/gastrointestinal involvement | 60 (86.95%) |
| Portal vein thrombosis | 5 (7.2%) |
| Distal superior mesenteric vein thrombosis | 1 (1.44%) |
| MCSI ≥8 | 69 (100%) |
Comparing sensitivity, specificity, PPV, NPV, and diagnostic accuracy for four scores for 69 CT severity cases based on literature cut-off values
PPV: positive predictive value; NPV: negative predictive value; APACHE: acute physiology and chronic health evaluation; BISAP: bedside index for the severity in acute pancreatitis; MGS: modified Glasgow score; CI: confidence interval
| Scoring system | Sensitivity, % (95% CI) | Specificity, % (95% CI) | PPV, % (95% CI) | NPV, % (95% CI) | Diagnostic accuracy, % (95% CI) |
| APACHE II | 63.7 (51.9-74.1) | 77.1 (60.98-87.93) | 84.6 (72.4-91.9) | 51.9 (38.69-64.9) | 68.2 (58.81-76.43) |
| BISAP | 31.8 (22.09-43.58) | 85.7 (70.62-93.74) | 81.4 (63.3-91.82) | 38.9 (28.84-50.13) | 50 (40.56-59.44) |
| MGS | 79.9 (68.78-87.51) | 31.4 (18.55-47.98) | 69.6 (58.77-78.66) | 44 (26.67-62.93) | 63.4 (53.88-72.08) |
| Ranson at admission | 44.9 (33.77-56.62) | 91.4 (77.62-97.04) | 91.1 (77.04-96.95) | 45.7 (34.57-57.3) | 60.5 (50.97-69.43) |
| Ranson at 48 hours | 63.7 (51.9-74.1) | 51.4 (35.57-67.01) | 72.1 (59.83-81.81) | 41.8 (28.38-56.67) | 59.6 (50.01-68.54) |
| Procalcitonin | 89.6 (82.79-93.38) | 100 (92.59-100) | 100 (96.44-100) | 80 (68.22-88.17) | 92.6 (87.65-95.77) |
Diagnostic values of four scoring systems and procalcitonin when all acute pancreatitis patients compared
PPV: positive predictive value; NPV: negative predictive value; APACHE: acute physiology and chronic health evaluation; BISAP: bedside index for the severity in acute pancreatitis; MGS: modified Glasgow score; CI: confidence interval
| Scoring system | Sensitivity, % (95% CI) | Specificity, % (95% CI) | PPV, % (95% CI) | NPV, % (95% CI) | Diagnostic accuracy, % (95% CI) |
| APACHE II | 50 (40.56-59.44) | 100 (93.98-100) | 100 (93.12-100) | 53.57 (44.37-62.54) | 68.29 (60.82-74.93) |
| BISAP | 25.96 (18.5-35.14) | 100 (93.98-100) | 100 (87.54-100) | 43.8 (35.77-52.16) | 53.05 (45.43-60.53) |
| MGS | 75.96 (66.92-83.15) | 100 (95.36-100) | 100 (95.36-100) | 70.59 (60.18-79.21) | 84.76 (78.46-89.46) |
| Ranson at admission | 32.69 (24.43-42.18) | 100 (93.98-100) | 100 (89.85-100) | 46.15 (37.82-54.71) | 57.32 (49.66-64.63) |
| Ranson at 48 hours | 58.65 (49.05-67.65) | 100 (93.98-100) | 100 (94.08-100) | 58.25 (48.6-67.31) | 73.78 (66.56-79.91) |
| Procalcitonin | 89.66 (82.79-93.38) | 100 (92.59-100) | 100 (96.44-100) | 80 (68.22-88.17) | 92.68 (87.65-95.77) |
Figure 1ROC curves four scores and procalcitonin in study patients
ROC: receiver operator characteristic; score 1: acute physiology and chronic health evaluation II; score 2: bedside index for the severity in acute pancreatitis; score 3: modified Glasgow score; score 4a: Ranson score at admission; score 4b: Ranson score 48 hours after admission.
Comparison of scoring systems in SAP patients with cut-off points generated by ROC curves
APACHE: acute physiology and chronic health evaluation; BISAP: bedside index for the severity in acute pancreatitis; MGS: modified Glasgow score; ROC: receiver operator characteristic
| Scoring system | With literature cut-off | With ROC curve generated study cut-off |
| APACHE | 66.34% (n=69) | 81.7% (n=85) |
| BISAP | 21.15% (n=22) | 55.76% (n=58) |
| MGS | 52.58% (n=55) | 52.58% (n=55) |
| Ranson at admission | 29.80% (n=31) | 75.96% (n=79) |
| Ranson at 48 hours | 34.61% (n=44) | 42.30% (n=62) |
| Procalcitonin | 100% (n=104) | 100% (n=104) |
Comparison of scoring systems for association with organ failure in study patients
APACHE: acute physiology and chronic health evaluation; BISAP: bedside index for the severity in acute pancreatitis; MGS: modified Glasgow score
| Scoring system | Sensitivity, % | Specificity, % | PPV, % | NPV, % | Diagnostic accuracy, % |
| APACHE II | 48.5 | 36.2 | 27.8 | 58.1 | 40.3 |
| BISAP | 8.5 | 55 | 8.8 | 54.2 | 39.4 |
| MGS | 68.5 | 20.2 | 30.3 | 56 | 36.5 |
| Ranson at admission | 14.2 | 68.1 | 18.5 | 61 | 50 |
| Ranson at 48 hours | 22.8 | 36.2 | 15.3 | 48 | 31.7 |
| Procalcitonin | 100 | 100 | 100 | 100 | 100 |
Mortality among acute pancreatitis patients predicted by various scores
APACHE: acute physiology and chronic health evaluation; BISAP: bedside index for the severity in acute pancreatitis; MGS: modified Glasgow score; ROC: receiver operator characteristic
| Scoring system | With literature cut-off | With ROC curve generated study cut-off |
| APACHE | 63.15% (n=12) | 42.1% (n=8) |
| BISAP | 42.1% (n=8) | 68.4% (n=13) |
| MGS | 63.1% (n=12) | 63.1% (n=12) |
| Ranson at admission | 26.3% (n=5) | 52.6% (n=10) |
| Ranson at 48 hours | 52.63% (n=10) | 57.89% (n=11) |
| Procalcitonin | 15% (n=3) | 47% (n=9) |